If you can’t see the video click here.
PORTAGE, Mich. — Medical marijuana patients in Portage have the option of getting medications delivered to their doorstep after a provision center was awarded a license for home delivery.
Lake Effect in Portage will deliver patients that have medical marijuana card, up to 2.5 ounces of flower buds or edibles a day.
“Delivery is all about the patients, comfort level and being attentive to there needs,” Steve Bliss, store manager, said
Bliss said being able to make home deliveries puts them ahead of the competition and their main priority is making sure patients get the medication they need.
Many of the Lake Effect patients said the delivery service was highly needed in the Kalamazoo area.
Ben Garvey, who has been a medical marijuana patient for almost 10 years, suffers from epilepsy and said he needs medication everyday, but sometimes its a struggle getting to and from the facility.
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce the appointment of Martin Landry to the position of Chief of Corporate Development & Strategy. Mr. Landry will be joining the Company’s management team as of May 27, 2019.
Martin Landry, CPA, CA has cumulated 20 years of experience in capital markets and accounting. Since 2013, Martin was at the forefront of the Canadian cannabis industry and witnessed its evolution firsthand. In his last position as Managing Director Equity Research at GMP Securities, he developed an extensive network in the cannabis industry. He is a seasoned investment professional and in 2018 and 2017, Martin ranked first amongst Canadian equity analysts for Small Cap/Special Situations research according to Brendan Wood International.
With the creation of this new pivotal position, Neptune takes a leap forward in the execution of its vision towards becoming a global leader in the offering of value added, differentiated science-based products for the legal cannabis and nutrition consumer product markets.
“We are extremely pleased to have Martin join our team as he takes on this new role as Chief of Corporate Development & Strategy. This appointment reflects our absolute commitment to having the best team to advance the Company’s strategic corporate initiatives. As a trusted professional with extensive knowledge of both the cannabis industry and consumer products, Martin will play a crucial role in developing and executing Neptune’s strategy to realize the Company’s growth ambition,” said Jim Hamilton, President and CEO of Neptune.
“I am joining Neptune at an exciting time to help drive the development and delivery of the Company’s strategic priorities. Also, I look forward to be part of a leadership team that will be dedicated to growing the business in the global marketplace and further leverage the great strides Neptune has already made in the health and wellness consumer product sector,” said Mr. Landry.
As Chief of Corporate Development & Strategy, Mr. Landry will oversee the development and implementation of Neptune’s corporate development strategy to help propel the Company’s leadership in its new growth trajectory, as well as certain key financial, and communication processes.
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions specializes in the extraction, purification and formulation of health and wellness products. Licensed by Health Canada to process cannabis at its 50,000-square-foot facility located in Sherbrooke, Quebec, Neptune brings decades of experience in the natural products sector to the legal cannabis industry. Leveraging its scientific and technological expertise, Neptune focuses on the development of value-added and differentiated products for the Canadian and global cannabis markets. Neptune’s activities also include the development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil®, and of a variety of marine and seed oils. Its head office is located in Laval, Quebec.
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements” within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes”, “belief”, “expects”, “intends”, “projects”, “anticipates”, “will”, “should” or “plans” to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Forward-looking information in this press release includes, but is not limited to, information or statements about our ability to successfully develop, produce, supply, promote or generate any revenue from the sale of any cannabis-based products in the legal cannabis market.
The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement and the “Cautionary Note Regarding Forward-Looking Information” section contained in Neptune’s latest Annual Information Form (the “AIF”), which also forms part of Neptune’s latest annual report on Form 40-F, and which is available on SEDAR at www.sedar.com, on EDGAR at www.sec.gov/edgar.shtml and on the investor section of Neptune’s website at www.neptunecorp.com. All forward-looking statements in this press release are made as of the date of this press release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in Neptune public securities filings with the Securities and Exchange Commission and the Canadian securities commissions. Additional information about these assumptions and risks and uncertainties is contained in the AIF under “Risk Factors”.
Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:http://www.prnewswire.com/news-releases/neptune-welcomes-martin-landry-as-chief-of-corporate-development–strategy-300848578.html
SOURCE Neptune Wellness Solutions Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2019/13/c8565.html
Investor Information: Canada, Pierre Boucher, MaisonBrison, 1.514.731.0000, email@example.com; United States, Carolyn Capaccio / Jody Burfening, LHA, 1.212.838.3777, firstname.lastname@example.org / email@example.com; Media Requests: Sabrina Di Blasio, Neptune Wellness Solutions, 514.258.8183, firstname.lastname@example.orgCopyright CNW Group 2019
Published at Mon, 13 May 2019 11:34:25 +0000
For years, counterfeiters have been creating and selling knockoffs of Rolex watches, Louis Vuitton handbags and Ray Ban sunglasses.
Now, it’s the marijuana industry’s turn.
Counterfeiters seeking to exploit the marijuana sector’s explosive growth are increasingly targeting knocking off cannabis products.
On December 20, farmers and entrepreneurs struck gold when Congress passed the The Agriculture Improvement Act of 2018, or the “Farm Bill.” The law uprooted hemp from the controlled substances list, approving it for industrial growth in all 50 states.
Four months later, hundreds of licenses to grow and process the newly-legalized plant — otherwise known as Cannabis sativa L — have been distributed to eager growers throughout New York State. Prior to the greenlight for industrial growth, growing hemp was restricted to academic research institutions, of which Cornell was among the first to receive a license in 2017.
Now, economic analysts are calling hemp the most lucrative cash crop farmers have seen in decades, with the industry projected to grow 18.3 percent each year over the next decade. Business is already booming. And Cornell will lend a hand in helping the crop succeed.
If you’ve ever been in the market for protein powder, you would know that navigating your way through all the different types out there can be an absolute minefield.
Not only do you have to consider things like taste and texture, above all, ingredients and nutritional profile can also be an automatic deal-breaker. Those with dietary requirements such as dairy-free may steer clear from whey protein. Similarly, those who follow a low-FODMAP diet will opt against pea protein—and almost everyone nowadays is mindful of sugar content, all-natural ingredients and zero fillers.
So when we heard that hemp seed might be the non-dairy, gut-friendly, hormone-balancing protein powder we’ve all been waiting for, we wanted to know more. We sat down with Georgia Branch, co-founder of Australian hemp brand, Hemple to learn all about the health benefits of hemp seed protein powder and why it makes a great addition to your diet.
A pilot study is currently underway in Australia investigating the efficacy of medicinal cannabis as a treatment for severe behavioral problems in intellectually disabled children. It’s hoped the research will eventually move into larger clinical trials following anecdotal reports that medicinal cannabis can reduce incidents of aggression and self-harm in children.
The study is being led by Daryl Efron, from the Murdoch Children’s Research Institute, and is initially just working with 10 children aged between eight and 16. This preliminary study is designed to first evaluate the practicalities and feasibility of the treatment ahead of a larger-scale trial.
“The medications most often prescribed for these children are stimulants, antidepressants and anti-psychotics, which all carry a risk of serious side-effects,” says Efron. “There is little research into new drugs to help these children, but medicinal cannabis has been shown to be effective to treat other medical conditions, including some severe epilepsies in children, and chemotherapy side effects and multiple sclerosis in adults.”
March 1st, Gov. Gretchen Whitmer (D-MI) signed executive order 2019-7. The order created the Marijuana Regulatory Agency, within the Department of Licensing and Regulatory Affairs (LARA). The agency will officially replace the Medical Marihuana Licensing Board this week.
The change involves more than just reprinting office stationary.
The new agency will be responsible for administering laws related to medical marijuana (which has been legal for a decade) and recreational marijuana (which Michigan voters approved last November).
Lt. Gov. John Fetterman told Democratic lawmakers on Monday that residents in 50 counties have shown strong support for legalizing recreational cannabis for adults.
Appearing Monday before a joint hearing of the House and Senate Democratic Policy committees, Fetterman shared the preliminary findings from his statewide recreational marijuana listening tour, which began in January, and will take him to each of Pennsylvania’s 67 counties to hear residents sound off on the policy debate.
Bills in the House and Senate would make recreational marijuana legal for all Pennsylvanians over the age of 21. But the legislation faces staunch opposition from Republican leaders in both chambers, who have final say on what bills make it to Gov. Tom Wolf’s desk.
The legal cannabis industry in North America is worth over $10 billion and employs more than a quarter of a million people, and yet the industry as a whole is decidedly still in its infancy. By comparison, the most recent future projections (from April 2019) expect the global legal cannabis market to be worth over $146 billion USD by the year 2025.
Given the potential for such great value, it is important that the industry has the correct tools to deal with this sort of growth without falling victim to those who may skirt the standards of safety and integrity for personal gain. For this, the cannabis industry may wish to look to the more established pharmaceutical and food and beverage industries for good industry standard practice.
(by Shamard Charles, M.D., NBC News) – The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent warning letters on April 2 to three companies that market CBD products, saying the companies are making false claims about treating diseases such as cancer and Alzheimer’s.
The agencies assert that three companies — Nutra Pure, PotNetwork Holdings, and Advanced Spine and Pain — are falsely advertising the effectiveness of supplements that contain cannabidiol, commonly known as CBD. The products are marketed under names such as “Hemp Oil,” “CBD Softgels,” “CBD for Dogs,” “Liquid Gold Gummies,” and “CBD Oil.”
One company in particular — Nutra Pure — advertises that scientific research supports their claims that their CBD product is an effective anti-seizure medication.